$21.18
0.150.71%
Last update: Nov 9, 4:00 PM
vTv Therapeutics Inc
VTVTNASDAQ
vTv Therapeutics fell 26.2% from $28.70 to $21.18, behind the S&P 500's +10.5%. Its worst day was Feb 5 (−14.8%), and its low came Nov 6 at $21.03.
Story events cover the past 12 months · Times ET
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
vTv Therapeutics shares rose 11.6%, while the S&P 500 fell 0.3%.
+11.6% · S&P 500 −0.3%
vTv Therapeutics closed at its highest level of the year, 48.8% above where the year started.
+0.8% · S&P 500 +0.6%
vTv Therapeutics shares fell 14.8%, while the S&P 500 fell 1.2%.
−14.8%, the year's worst day · S&P 500 −1.2%
vTv Therapeutics shares rose 13.4%, while the S&P 500 rose 0.7%.
+13.4% · S&P 500 +0.7%
EPS of $-0.58 beat the $-1.04 estimate on $0.00 revenue.
+0.2% · S&P 500 −0.1%
vTv Therapeutics shares fell 13.8%, while the S&P 500 fell 0.4%.
−13.8% · S&P 500 −0.4%
EPS of $1.65 beat the $0.24 estimate on $36.8M revenue (est. $12.0M).
+21.4%, the year's best day · S&P 500 +0.8%
EPS of $-1.05 missed the $-0.94 estimate on $0.00 revenue (est. $320,000.00).
+0.6% · S&P 500 −0.2%
EPS of $-0.94 beat the $-1.07 estimate on $0.00 revenue (est. $225,000.00).
−3.3% · S&P 500 +0.3%
Where it ended: a close of $21.18 on Nov 9, 2026. Up next: Q4 2026 earnings on Mar 9, 2027 (EPS est. $-1.21).
Nothing in the past 12 months.
All VTVT dividend history
